Evoke Pharma (EVOK) Earnings Date, Estimates & Call Transcripts → Forget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THIS (From Paradigm Press) (Ad) Free EVOK Stock Alerts $0.46 +0.02 (+4.57%) (As of 04/26/2024 ET) Add Compare Share Share EarningsStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesSEC FilingsShort InterestSocial MediaStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesSEC FilingsShort InterestSocial Media Earnings SummaryUpcoming Earnings DateMay. 20EstimatedActual EPS (Mar. 14) -$0.59 Missed By -$0.59 Read Call TranscriptListen to Call Get Evoke Pharma Earnings AlertsEnter your email address below to receive the latest news and earnings results for EVOK and its competitors with MarketBeat's FREE daily newsletter. Skip Charts & View Estimated and Actual Earnings DataEarnings Per ShareRevenueEVOK Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.EVOK Estimated and Actual Revenue by Quarter Estimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Ad Paradigm PressForget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THISYou might have seen that Bitcoin was one of the best performing assets of 2023. It gained 164%. But a crypto millionaire who has been tracking the space for more than a decade has ABANDONED Bitcoin. He found something better.Click here to find out that this 8,788% cryptocurrency is. EVOK Earnings Date and InformationEvoke Pharma last announced its earnings data on March 14th, 2024. The specialty pharmaceutical company reported ($0.59) EPS for the quarter. The business had revenue of $1.68 million for the quarter. Evoke Pharma has generated ($2.33) earnings per share over the last year (($2.33) diluted earnings per share). Evoke Pharma has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Monday, May 20th, 2024 based off prior year's report dates.Read More Evoke Pharma Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript 5/20/2024Estimated)------- 3/14/2024Q4 2023-($0.59)($0.59)($0.59)-$1.68 million 11/9/2023Q3 2023-($0.51)($0.51)($0.51)-$1.56 million8/10/2023Q2 2023-($0.56)($0.56)($0.56)-$1.13 million5/15/2023Q1 2023-($0.67)($0.67)($0.67)-$0.81 million3/21/2023Q4 2022-($0.53)($0.53)($0.53)-$0.80 million 11/9/2022Q3 2022-($0.60)($0.60)($0.60)-$0.83 million Get the Latest News and Ratings for EVOK and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Evoke Pharma and its competitors with MarketBeat's FREE daily newsletter. 8/10/2022Q2 2022-($0.71)($0.71)($0.71)-$0.46 million 5/10/2022Q1 2022-($0.84)($0.84)($0.84)-$0.42 million 3/8/2022Q4 2021-($0.60)($0.60)($0.05)-$0.36 million11/10/2021Q3($0.84)($0.72)+$0.12($0.06)-$0.93 million 8/12/2021Q2 2021($0.96)($0.84)+$0.12($0.07)-$0.24 million 5/12/2021Q1 2021($0.72)($0.96)($0.24)($0.08)$1.40 million$0.09 million Evoke Pharma Earnings - Frequently Asked Questions When is Evoke Pharma's earnings date? Evoke Pharma has not confirmed its next earnings publication date, but the company's estimated earnings date is Monday, May 20th, 2024 based off last year's report dates. Learn more on EVOK's earnings history. How can I listen to Evoke Pharma's earnings conference call? The conference call for Evoke Pharma's latest earnings report can be listened to online. Listen to Conference Call How can I read Evoke Pharma's conference call transcript? The conference call transcript for Evoke Pharma's latest earnings report can be read online. Read Transcript How much revenue does Evoke Pharma generate each year? Evoke Pharma (NASDAQ:EVOK) has a recorded annual revenue of $5.18 million. How much profit does Evoke Pharma generate each year? Evoke Pharma (NASDAQ:EVOK) has a recorded net income of -$7.79 million. EVOK has generated -$2.33 earnings per share over the last four quarters. More Earnings Resources from MarketBeat Related Companies: CING Earnings VRPX Earnings MBIO Earnings KTRA Earnings NEXI Earnings THAR Earnings ZVSA Earnings PCSA Earnings GNPX Earnings GOVX Earnings Earnings Tools: Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country: U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Australia Earnings Reports Latest Articles: GE Aerospace is Ready for Liftoff After Strong EarningsTaiwan Semiconductor Earnings: AI Dominance and Future OutlookCSX Co.: The Railroad Powering Ahead with an Earnings Beat What's Driving Tesla Lower Ahead of its Earnings?Blackrock vs. State Street: Earnings in a Volatile MarketWhat to Expect From the Q1 Earnings Reporting SeasonLululemon Stock Implodes Post Earnings, Guidance Muted This page (NASDAQ:EVOK) was last updated on 4/27/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThese AI trades triggered this morning (545% return)Prosper Trading AcademyHe Is Giving Away BitcoinCrypto Swap ProfitsThe A.I. story nobody is telling you (Read ASAP)TradeSmithFed launches fourth dollar overhaulStansberry ResearchBiden out June 13; Kamala won’t replace him?Paradigm PressMan Who Predicted 2008: “This Will be Worse.”AltimetryExposed: 10 CENT Crypto to Explode April 20th?True Market Insiders Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Evoke Pharma, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
